Memphasys Limited (ASX: MEM)
Health Care · Life Sciences Tools & Services · AU
AU$0.01
-14.29% today · +50.0% 1Y
Memphasys Limited (ASX: MEM) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $13.28M and employs 24 people.
Over the last twelve months the share price has gained 50.0%, trading between 0.00 and 0.01.
Tweenvest scores Memphasys Limited across four factors: quality 20/100, value 59/100. Its strongest factor is value.
MEM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.28M
- Revenue (TTM)
- $142.73K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- AU$0.01
- 52-week low
- AU$0.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.09B
- Employees
- 24
- Next earnings
- —
About Memphasys Limited
Memphasys Limited, an Australian enterprise, is dedicated to the development, manufacturing, and distribution of advanced cell and protein separation technologies, alongside associated consumable goods, for the healthcare, veterinary, and biotechnology sectors. Its leading innovation is Felix, an automated device engineered to swiftly and gently isolate high-quality sperm from raw semen samples, primarily for use in human in vitro fertilization (IVF) procedures. The company's product portfolio also includes ROSA, a rapid oxidative stress assay; the Samson Device, designed for quick equine pregnancy prediction; SemPort, a system for central laboratory human semen analysis from geographically dispersed donors; and AI-Port, an ambient temperature semen transport solution for animal artificial insemination. Incorporated in 2006, the company was formerly known as NuSep Holdings Limited until its rebranding to Memphasys Limited in July 2016, and is headquartered in Homebush, Australia.
- ISIN
- AU000000MEM5
- Founded
- 2006
- Listed since
- May 11, 2007
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF592.20 | +1.09% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.